Terms: = Breast cancer AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18 AND Prognosis
35 results:
1. A potential tumor marker: Chaperonin containing TCP‑1 controls the development of malignant tumors (Review).
Zheng L; Chen X; Zhang L; Qin N; An J; Zhu J; Jin H; Tuo B
Int J Oncol; 2023 Sep; 63(3):. PubMed ID: 37539774
[TBL] [Abstract] [Full Text] [Related]
2. STAT3 inhibition enhances gemcitabine sensitivity in pancreatic cancer by suppressing EMT, immune escape and inducing oxidative stress damage.
Guo H; Hu Z; Yang X; Yuan Z; Gao Y; Chen J; Xie L; Chen C; Guo Y; Bai Y
Int Immunopharmacol; 2023 Oct; 123():110709. PubMed ID: 37515849
[TBL] [Abstract] [Full Text] [Related]
3. Clinical significance of microinvasive breast cancer across the different subtypes and human epidermal growth factor receptor 2 expression levels.
Lee SY; Yoo TK; Kim J; Chung IY; Ko BS; Kim HJ; Lee JW; Son BH; Lee SB
Breast Cancer Res Treat; 2023 Jul; 200(1):47-61. PubMed ID: 37184775
[TBL] [Abstract] [Full Text] [Related]
4. Asiaticoside hampers epithelial-mesenchymal transition by promoting PPARG expression and suppressing P2RX7-mediated TGF-β/Smad signaling in triple-negative breast cancer.
Huang X; Jia Z; Li X; Hu Z; Yu X; Xia J
Phytother Res; 2023 May; 37(5):1771-1786. PubMed ID: 36444395
[TBL] [Abstract] [Full Text] [Related]
5. Cyclin-dependent kinase subunit2 (CKS2) promotes malignant phenotypes and epithelial-mesenchymal transition-like process in glioma by activating TGFβ/SMAD signaling.
Feng F; Zhao Z; Cai X; Heng X; Ma X
Cancer Med; 2023 Mar; 12(5):5889-5907. PubMed ID: 36284444
[TBL] [Abstract] [Full Text] [Related]
6. Downregulation of Elovl5 promotes breast cancer metastasis through a lipid-droplet accumulation-mediated induction of TGF-β receptors.
Kieu TL; Pierre L; Derangère V; Perrey S; Truntzer C; Jalil A; Causse S; Groetz E; Dumont A; Guyard L; Arnould L; de Barros JP; Apetoh L; Rébé C; Limagne E; Jourdan T; Demizieux L; Masson D; Thomas C; Ghiringhelli F; Rialland M
Cell Death Dis; 2022 Sep; 13(9):758. PubMed ID: 36056008
[TBL] [Abstract] [Full Text] [Related]
7. RNF12 is regulated by AKT phosphorylation and promotes TGF-β driven breast cancer metastasis.
Huang Y; Liu S; Shan M; Hagenaars SC; Mesker WE; Cohen D; Wang L; Zheng Z; Devilee P; Tollenaar RAEM; Li Z; Song Y; Zhang L; Li D; Ten Dijke P
Cell Death Dis; 2022 Jan; 13(1):44. PubMed ID: 35013159
[TBL] [Abstract] [Full Text] [Related]
8. TAD1822-7 induces ROS-mediated apoptosis of HER2 positive breast cancer by decreasing E-cadherin in an EphB4 dependent manner.
Zhu M; Tang X; Gong Z; Tang W; Zhang Y
Life Sci; 2021 Nov; 285():119954. PubMed ID: 34520770
[TBL] [Abstract] [Full Text] [Related]
9. Angiomotin-p130 inhibits vasculogenic mimicry formation of small cell lung cancer independently of smad2/3 signal pathway.
Li D; Shen Y; Ren H; Wang L; Yang J; Wang Y
J Bioenerg Biomembr; 2021 Jun; 53(3):295-305. PubMed ID: 33712992
[TBL] [Abstract] [Full Text] [Related]
10. MMP11 promotes the proliferation and progression of breast cancer through stabilizing smad2 protein.
Zhuang Y; Li X; Zhan P; Pi G; Wen G
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649832
[TBL] [Abstract] [Full Text] [Related]
11. Profilin 2 (PFN2) promotes the proliferation, migration, invasion and epithelial-to-mesenchymal transition of triple negative breast cancer cells.
Ling Y; Cao Q; Liu Y; Zhao J; Zhao Y; Li K; Chen Z; Du X; Huo X; Kang H; Chen Z
Breast Cancer; 2021 Mar; 28(2):368-378. PubMed ID: 33047272
[TBL] [Abstract] [Full Text] [Related]
12. MicroRNA-455-3p mediates GATA3 tumor suppression in mammary epithelial cells by inhibiting TGF-β signaling.
Zeng Y; Gao T; Huang W; Yang Y; Qiu R; Hou Y; Yu W; Leng S; Feng D; Liu W; Teng X; Yu H; Wang Y
J Biol Chem; 2019 Oct; 294(43):15808-15825. PubMed ID: 31492753
[TBL] [Abstract] [Full Text] [Related]
13. Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers.
Hancock BA; Chen YH; Solzak JP; Ahmad MN; Wedge DC; Brinza D; Scafe C; Veitch J; Gottimukkala R; Short W; Atale RV; Ivan M; Badve SS; Schneider BP; Lu X; Miller KD; Radovich M
Breast Cancer Res; 2019 Aug; 21(1):87. PubMed ID: 31383035
[TBL] [Abstract] [Full Text] [Related]
14. Long Non-Coding RNA TFAP2A-AS1 Inhibits Cell Proliferation and Invasion in breast cancer via miR-933/smad2.
Zhou B; Guo H; Tang J
Med Sci Monit; 2019 Feb; 25():1242-1253. PubMed ID: 30768589
[TBL] [Abstract] [Full Text] [Related]
15. SMYD3 promotes the epithelial-mesenchymal transition in breast cancer.
Fenizia C; Bottino C; Corbetta S; Fittipaldi R; Floris P; Gaudenzi G; Carra S; Cotelli F; Vitale G; Caretti G
Nucleic Acids Res; 2019 Feb; 47(3):1278-1293. PubMed ID: 30544196
[TBL] [Abstract] [Full Text] [Related]
16. CD151 promotes breast cancer metastasis by activating TGF-β1/Smad signaling pathway.
Zhao SJ; Zhao HD; Li J; Zhang H; Gao DT; Wang Q
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7314-7322. PubMed ID: 30468476
[TBL] [Abstract] [Full Text] [Related]
17. Oncogenic activity of poly (ADP-ribose) glycohydrolase.
Marques M; Jangal M; Wang LC; Kazanets A; da Silva SD; Zhao T; Lovato A; Yu H; Jie S; Del Rincon S; Mackey J; Damaraju S; Alaoui-Jamali M; Witcher M
Oncogene; 2019 Mar; 38(12):2177-2191. PubMed ID: 30459355
[TBL] [Abstract] [Full Text] [Related]
18. Patterns of copy number alterations in primary breast tumors of South African patients and their impact on functional cellular pathways.
Lupicki K; Elifio-Esposito S; Fonseca AS; Weber SH; Sugita B; Langa BC; Pereira SRF; Govender D; Panieri E; Hiss DC; Abdul-Rasool S; Cavalli LR
Int J Oncol; 2018 Dec; 53(6):2745-2757. PubMed ID: 30320392
[TBL] [Abstract] [Full Text] [Related]
19. Sialylation of vasorin by ST3Gal1 facilitates TGF-β1-mediated tumor angiogenesis and progression.
Yeo HL; Fan TC; Lin RJ; Yu JC; Liao GS; Chen ES; Ho MY; Lin WD; Chen K; Chen CH; Hung JT; Wu JC; Chang NC; Chang MD; Yu J; Yu AL
Int J Cancer; 2019 Apr; 144(8):1996-2007. PubMed ID: 30252131
[TBL] [Abstract] [Full Text] [Related]
20. Nafamostat mesilate negatively regulates the metastasis of triple-negative breast cancer cells.
Mander S; You DJ; Park S; Kim DH; Yong HJ; Kim DS; Ahn C; Kim YH; Seong JY; Hwang JI
Arch Pharm Res; 2018 Feb; 41(2):229-242. PubMed ID: 29196918
[TBL] [Abstract] [Full Text] [Related]
[Next]
